The Charter of the French Language and its regulations govern the consultation of English-language content.


2301 Avenue d’Estimauville Québec (Québec) G1E 0N5 Canada
Professeur titulaire
Département d’ophtalmologie et ORL-chirurgie cervico-faciale
Faculté de Médecine, Université Laval
Directeur du laboratoire d’électrophysiologie visuelle et de photobiologie
Directeur scientifique adjoint à la recherche clinique, Centre de recherche CERVO
Axe de recherche:
Neurosciences cliniques et cognitives
Marc Hébert est un spécialiste de l’étude de l’horloge biologique, ou chronobiologie, et de la photobiologie, qui est l’étude des effets de la lumière sur le cerveau. Sa recherche a montré que la lumière a des effets importants sur l’humeur, et que la lumière bleue en particulier affecte l’horloge biologique. Ces découvertes ont permis de développer des technologies qui ont des retombées directes sur la santé des gens, par l’utilisation de la lumière pour diminuer l’intensité du trouble affectif saisonnier et pour aider les travailleurs de nuit à rester alertes au travail, et à mieux dormir ensuite.
Les technologies développées grâce aux recherches du Pr Hébert ont été testées chez des travailleurs de nuit et ont eu un impact positif, menant le chercheur à les commercialiser afin de les rendre accessibles à un plus grand nombre de personnes et d’entreprises. La compagnie Chronophotonix fondée par Marc Hébert, fait d’ailleurs partie des dix premières compagnies à avoir reçu un financement important du Fonds InnovExport. Ce fonds, constitué par le gouvernement du Québec et des investisseurs publics et privés, a pour but de soutenir des entreprises innovantes visant les marchés internationaux.
Le professeur Hébert s’intéresse aussi particulièrement à la réponse de la partie sensible de l’œil, la rétine, qui est une extension du cerveau dont l’activité électrique peut être mesurée de manière non-invasive, par une technique appelée électrorétinographie. La rétine agit comme miroir du cerveau pour informer les chercheurs sur son fonctionnement. En collaboration avec les chercheurs Michel Maziade et Chantal Mérette, aussi du Centre de recherche CERVO, ces études ont mené à la démonstration que les patients souffrant de dépression majeure, de schizophrénie, et d’autres maladies psychiatriques présentent des profils de réponse à l’électrorétinogramme qui permettent de les distinguer des profils des personnes en santé. Ces réponses spécifiques pourraient être utilisées comme biomarqueurs pour aider au diagnostic précoce de maladies psychiatriques, pouvant ainsi permettre une intervention personnalisée pour ralentir leur progression, ou les prévenir. La compagnie diaMentis a été lancée pour faciliter le développement, la distribution et la commercialisation de cette nouvelle technologie de diagnostic, qui constitue un des premiers pas vers une médecine personnalisée en santé mentale.
Touche-à-tout, le Pr Hébert s’intéresse également à la lumière en architecture, et à ses impacts sur les personnes.
Le laboratoire d’électrophysiologie visuelle et de photobiologie (LEVP) opère dans de nombreux secteurs de recherche. Toutefois, tous les projets possèdent un point en commun: soit la rétine de l’œil. En effet, que ce soit les études en chronobiologie chez le travailleur de nuit ou celles utilisant la technique d’électrorétinographie (ERG) dans le domaine de la psychiatrie, la rétine y joue toujours un rôle clé.
Les diverses recherches effectuées sur le travail de nuit ou sur le Trouble Affectif Saisonnier (TAS) utilisent et étudient l’effet de la lumière tant au niveau de la rétine que du cerveau. Dans d’autres situations, nous étudions les réactions de la rétine dans diverses maladies psychiatriques. En effet, en tant qu’extension du cerveau, celle-ci peut nous donner un aperçu de la neurochimie centrale. Il s’agit de l’un des laboratoires canadiens les mieux équipés en électrophysiologie visuelle avec 7 plateformes en électrophysiologie humaine ou animale. De plus, plusieurs publications sont produites chaque année et les recherches faites par le Dr Marc Hébert et son laboratoire reçoivent une forte couverture médiatique[i] (ex. Daily Planet de BBC.)
[i] liste non exhaustive fournie à titre d’exemple
http://lecodechastenay.telequebec.tv/emission.aspx?id=67
http://www.discovery.ca/Video?vid=795428
http://pilule.telequebec.tv/occurrence.aspx?id=569
http://www.maxisciences.com/horloge-biologique/une-lumiere-bleue-pour-reguler-notre-rythme-biologique-la-nuit_art26014.html
Valérie Gagné, maîtrise, co-direction avec Claude MH Demers
Marc-André Dubois, doctorat, co-direction avec Simon Grondin
Victoria Soto Linan, doctorat, co-direction avec Martin Lévesque
Carolina Belen Espinoza Sanhueza, post-doctorat, co-direction avec Claude MH Demers
Katherine Picard, coordonnatrice, Axe 3, Alliance Santé Mental du Québec
Le Dr Hébert est professeur titulaire d’ophtalmologie à l’Université Laval à Québec. Il a commencé sa carrière en recherche après avoir obtenu un baccalauréat en psychologie de l’Université d’Ottawa, et un doctorat en neurobiologie de l’Université de Montréal, suivie de quatre années de formation postdoctorale en chronobiologie et électrophysiologie visuelle d’abord au centre médical Rush Presbyterian St-Luke à Chicago puis, à l’Université de l’Alberta. Il est actuellement le directeur de l’Axe des Neurosciences cliniques et cognitives à l’Institut universitaire en santé mentale de Québec et co-directeur du Centre de recherche thématique en neurosciences à l’Université Laval.
Le Dr Hébert concentre ses recherches sur la lumière et l’œil. Dans certaines recherches il a étudié l’impact de la sensibilité à la lumière chez les patients atteints de troubles affectifs saisonniers et dans d’autres, utilisé la lumière pour améliorer la vigilance chez les travailleurs de nuit. Il a été président de la Société pour le traitement Lumière et rythmes biologiques à de 2010 à 2013 et il est actuellement rédacteur en chef de la revue ChronoPhysiology and Therapy . Il est aussi directeur scientifique de la Fondation des maladies de l’oeil et lieutenant-colonel honoraire de la 5e Ambulance de campagne de Valcartier. En 2008, il a été sélectionné comme l’une des 19 personnalités les plus fascinantes de la ville de Québec par Scope Magazine. Il est le fondateur de deux entreprises dérivées, Chronophotonix dont le but est d’améliorer la vigilance des conducteurs et travailleurs de nuit avec la lumière et plus récemment diaMentis qui utilise la réponse rétinienne à la lumière pour détecter des troubles psychiatriques. Un conférencier accomplit, le Dr Hébert a fait de nombreuses apparitions dans les médias au cours des années à titre d’expert de la lumière, soit pour améliorer l’humeur chez les personnes atteintes de dépression hivernale ou pour faciliter l’adaptation au travail de nuit.
2010/6 – 2014/6 Bourse de carrière Chercheur-boursier senior FRSQ
2009/6 – 2012/6 Président – Society for Light Treatments and Biological Rhythms
2008/12 Directeur Scientifique – Fondation des maladies de l’oeil
2008/12 Personnalités fascinantes du Québec – Scope Magazine Québec
Marie-Soleil Vallière; Marc-André Dubois; Marc Hébert
Secondary exploratory discrete wavelet analysis of the electroretinogram in adults with ADHD Article de journal
Dans: Prog Neuropsychopharmacol Biol Psychiatry, vol. 150, p. 111960, 2026, ISSN: 1878-4216.
@article{pmid42830170,
title = {Secondary exploratory discrete wavelet analysis of the electroretinogram in adults with ADHD},
author = {Marie-Soleil Vallière and Marc-André Dubois and Marc Hébert},
doi = {10.1016/j.pnpbp.2026.111960},
issn = {1878-4216},
year = {2026},
date = {2026-10-01},
journal = {Prog Neuropsychopharmacol Biol Psychiatry},
volume = {150},
pages = {111960},
abstract = {BACKGROUND: Conventional electroretinographic (ERG) analyses identified sex-specific retinal differences in adults with attention-deficit/hyperactivity disorder (ADHD). We applied the discrete wavelet transform (DWT) to the same recordings to characterize multiscale time-frequency features.nnMETHODS: ERGs from 25 adults with ADHD and 25 age- and sex-matched controls (16 female and 9 male pairs) were analyzed at seven flash intensities. Six DWT descriptors were extracted, and global scores averaged across intensities. Paired comparisons used false-discovery-rate correction. Secondary analyses examined intensity, sex, eyes, inter-eye agreement, within-session repeatability, current medication status, and exploratory classification.nnRESULTS: Global 40a and 20b values were lower in ADHD (Cohen's dz. = -0.63 and - 0.60; FDR q = 0.020 for both). Differences increased with flash intensity and had the same direction in female and male pairs and both eyes, without significant group × sex or group × eye interactions. Findings were stable across participant- and intensity based sensitivity analyses. Inter-eye ICC(A,1) was 0.750 for 40a and 0.865 for 20b; bilateral within-session ICC(A,1) values ranged from 0.839 to 0.981. Reductions were also present among the eight ADHD participants reporting no current ADHD medication use (dz = -0.74 and - 0.84). Exploratory leave-one-pair-out AUCs ranged from 0.653 to 0.731.nnCONCLUSIONS: DWT analysis identified lower 40a and 20b values as candidate retinal time-frequency features of ADHD. Their consistency across sensitivity analyses, sexes, eyes, medication strata, and repeated measurements supports prospective evaluation in independent, clinically characterized cohorts.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Jonathan Munro; Andrée-Anne Lavigne; Shirley Fecteau; Thérèse Di Paolo; Marc Hébert; Martin Parent
Improving Parkinson’s disease diagnosis by non-invasive detection of retinal biomarkers in MPTP monkeys using ERG and pupillometry Article de journal
Dans: NPJ Parkinsons Dis, vol. 12, no 1, 2026, ISSN: 2373-8057.
@article{pmid42236736,
title = {Improving Parkinson's disease diagnosis by non-invasive detection of retinal biomarkers in MPTP monkeys using ERG and pupillometry},
author = {Jonathan Munro and Andrée-Anne Lavigne and Shirley Fecteau and Thérèse Di Paolo and Marc Hébert and Martin Parent},
doi = {10.1038/s41531-026-01391-y},
issn = {2373-8057},
year = {2026},
date = {2026-06-01},
journal = {NPJ Parkinsons Dis},
volume = {12},
number = {1},
abstract = {Parkinson's disease (PD) diagnosis is currently made by clinical observation of motor symptoms when around 50% of dopamine neurons in the substantia nigra pars compacta are already lost. Non-motor symptoms, such as vision problems, occur earlier during disease progression and could be caused by altered retinal functioning. Various techniques exist to detect retinal alterations and, therefore, could provide biomarkers for earlier diagnosis of PD. The aim of this project is to determine potential retinal biomarkers for PD by using electroretinography (ERG) and pupillometry. In vivo measurements were performed on four non-human primates, before and after they were rendered parkinsonian by administration of 1-méthyl-4-phényl-1,2,3,6-tetrahydropyridine (MPTP), a neurotoxin that induces degeneration of dopamine neurons. ERG results showed a significant increase in photopic b-wave implicit time and reduced oscillatory potential (OP) amplitudes in both photopic and scotopic conditions following MPTP administration. The post-illumination pupillary response showed a consistently larger pupil diameter post-MPTP. Post-mortem examination revealed a significant thinning of the outer nuclear retinal layer. Tyrosine hydroxylase and melanopsin-containing cells were reduced in MPTP-intoxicated monkeys. Altogether, these results indicate that MPTP intoxication leads to functional retinal changes detectable by ERG and pupillometry, possibly attributed to cellular alterations.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Arina Ujevco; Cécile Le Page; Marc Corbière; Stéphane Guay; Martin Lepage; Marc Hébert; Robert-Paul Juster; Enzo Cipriani; Charles-Édouard Giguère; Lionel Cailhol; Pierre Orban; Stéphane Potvin; Andrée-Ann Baril; Thomas Beaudry; Sophie Blais-Michaud; Mallar Chakravarty; Alyssa Dai; Simon Ducharme; Pierre Marquet; Clara Morin; Naguib Mechawar; Jean-Baptiste Poline; Martin Roy; Claudia Savard; Sebastian Urchs; Vincent Taschereau-Dumouchel
[The data and metadata repository of the Québec Mental Health Alliance] Article de journal
Dans: Sante Ment Que, vol. 51, no 2, p. 205–232, 2026, ISSN: 1708-3923.
@article{pmid42550440,
title = {[The data and metadata repository of the Québec Mental Health Alliance]},
author = {Arina Ujevco and Cécile Le Page and Marc Corbière and Stéphane Guay and Martin Lepage and Marc Hébert and Robert-Paul Juster and Enzo Cipriani and Charles-Édouard Giguère and Lionel Cailhol and Pierre Orban and Stéphane Potvin and Andrée-Ann Baril and Thomas Beaudry and Sophie Blais-Michaud and Mallar Chakravarty and Alyssa Dai and Simon Ducharme and Pierre Marquet and Clara Morin and Naguib Mechawar and Jean-Baptiste Poline and Martin Roy and Claudia Savard and Sebastian Urchs and Vincent Taschereau-Dumouchel},
issn = {1708-3923},
year = {2026},
date = {2026-01-01},
journal = {Sante Ment Que},
volume = {51},
number = {2},
pages = {205--232},
abstract = {Objectives In the era of artificial intelligence, our understanding of mental health challenges depends heavily on our ability to generate and analyze large-scale datasets. Accordingly, the Data Valorization Axis of the Québec Mental Health Alliance (ASMQ) was established in 2024 to create a comprehensive repository of open mental health data and metadata in Québec. This initiative's mandate is to facilitate the indexing and discoverability of data and metadata collected in Québec, notably at the 3 main mental-health research centers of the Fonds de recherche du Québec: the Centre de recherche de l'Institut universitaire en santé mentale de Montréal (CR-IUSMM), the Centre de recherche CERVO and the Centre de recherche Douglas. Methods To build the Alliance repository, researchers and clinicians at ASMQ affiliated institutions were directly invited to index the datasets available in their laboratories. Nine databases were identified, and some are currently accessible via online-sharing platforms: Neurobagel, Maelstrom, and the Atlas of Longitudinal Datasets. Here, we present a description of the data contained in the various databases. Results To date, the data and metadata of 11,570 participants (26% psychosis and schizophrenia, 21% personality disorder, 19% mood disorder, 12% substance use, 10% bipolar disorder, 9% anxiety disorder) across 8 biobanks and datasets have been shared online through the Alliance repository. The biobank metadata includes various demographic (e.g. age, sex, gender, level of education), medical (e.g. psychiatric and physical diagnoses, medication use), psychosocial (e.g. social functioning, quality of life, depressive symptoms), anthropometric (e.g. height, weight), metabolic, behavioral (e.g. sleep, consumption of non-food products), cognitive (e.g. performance on neurophysiological tests), and medical-imaging data. Additionally, general information on governance and procedures for accessing and contributing new data to the repository is provided. Impact The Québec Mental Health Alliance repository enhances the visibility and accessibility of mental-health data in Québec, facilitating the sharing and dissemination of domain-specific data and metadata. The repository also aims to facilitate the harmonization of access procedures and experimental protocols. By advancing open science in Québec, the Alliance repository can catalyze scientific breakthroughs that rely on the analysis of large-scale datasets. This initiative could eventually be extended to other health institutions across Québec.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Julia Maruani; Lily Vissouze; Héloise Rach; Marc Hébert; Michel Lejoyeux; Patrice Bourgin; Pierre A Geoffroy
A study on electroretinography as a biomarker for seasonal vulnerability in depression Article de journal
Dans: Transl Psychiatry, vol. 16, no 1, p. 16, 2025, ISSN: 2158-3188.
@article{pmid41257974,
title = {A study on electroretinography as a biomarker for seasonal vulnerability in depression},
author = {Julia Maruani and Lily Vissouze and Héloise Rach and Marc Hébert and Michel Lejoyeux and Patrice Bourgin and Pierre A Geoffroy},
doi = {10.1038/s41398-025-03737-1},
issn = {2158-3188},
year = {2025},
date = {2025-11-01},
journal = {Transl Psychiatry},
volume = {16},
number = {1},
pages = {16},
abstract = {Depressive disorders involve disruptions in light signal processing. Seasonal Affective Disorder (SAD) has been linked to abnormalities in phototransduction, including impaired retinal responses and sleep disturbances. Similar retinal anomalies have been observed in Major Depressive Episode (MDE) patients without seasonal pattern. However, no study has directly compared light-signaling biomarkers between SAD and non-seasonal MDE using sleep assessments and electroretinography (ERG) measures. This study aims to develop a model combining clinical and ERG markers to predict seasonality in MDE patients. Patients with MDE (N = 320) were classified based on their vulnerability to seasonality using the Global Seasonality Score (GSS) from the Seasonal Pattern Assessment Questionnaire (SPAQ), with a threshold of ≥ 11 indicating seasonal vulnerability. This dimensional approach provides a more nuanced reflection of underlying pathophysiological mechanisms than the categorical DSM-5-TR classification of SAD. Subjective sleep, psychiatric, and ERG biomarkers were analyzed. Significant variables were entered into a Backward Stepwise Logistic Regression (N = 35, subset of participants who had all available data including ERG measures), and model performance was assessed using sensitivity, specificity, accuracy, AUC, ROC curve, and Youden's index. The model retained six predictors: reduced bipolar cell amplitude (rods), increased cone response amplitude at 7 cd·s⁻¹·m⁻², increased daytime sleepiness, higher depression severity, younger age, and female gender. It demonstrated good discriminative power (AUC = 0.861, sensitivity = 0.905, specificity = 0.714, Youden's index = 0.619). The model effectively distinguishes seasonal from non-seasonal MDE, explaining 30.5% of the variance. ERG is a promising tool for identifying biomarkers of Seasonal Vulnerability in depression. Enhancing predictive approaches with multimodal diagnostic and longitudinal data could further improve early detection and personalized interventions.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Victoria Soto Linan; Marc Hébert; Martin Lévesque
Enhancing the diagnostic potential of electroretinography in Parkinson’s disease: A review of protocol and cohort criteria Article de journal
Dans: J Parkinsons Dis, vol. 15, no 4, p. 694–709, 2025, ISSN: 1877-718X.
@article{pmid40530583,
title = {Enhancing the diagnostic potential of electroretinography in Parkinson's disease: A review of protocol and cohort criteria},
author = {Victoria Soto Linan and Marc Hébert and Martin Lévesque},
doi = {10.1177/1877718X251331863},
issn = {1877-718X},
year = {2025},
date = {2025-06-01},
journal = {J Parkinsons Dis},
volume = {15},
number = {4},
pages = {694--709},
abstract = {Electroretinography has emerged as a promising tool for identifying retinal functional anomalies in major psychiatric and neurodevelopmental disorders, such as schizophrenia, major depressive disorder, bipolar disorder, and autism spectrum disorder, positioning it as a potential biomarker of monoaminergic dysfunction. However, despite its potential, electroretinography studies in Parkinson's disease (PD) over the past decades have been inconsistent, largely due to variations in research methodologies. These limitations diminish its potential and hinder the association between retinal electrophysiological responses and PD neuropathology. To address this challenge, this review examines the most relevant sources of data variability and reduced reproducibility in electroretinography studies aimed at detecting a retinal functional signature characteristic of PD. We propose the consolidation of four key protocol factors and five cohort criteria to enhance the diagnostic accuracy of electroretinography in PD biomarker research. As electroretinography protocols are adapted from their clinical origins for research purposes, we argue that careful attention must be given to electrode type and placement, as well as to factors like age, sex, disease duration and severity, medication intake, psychiatric conditions, and comorbidities in cohort selection to ensure reproducible results. Suggesting that past inconsistencies in these areas may explain the variability in reported results and contribute to the lack of consensus on which electroretinography parameters comprise a disease signature in PD, we ultimately offer recommendations to improve the utility of electroretinography techniques as early biomarkers for PD.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Mojtaba Parsaee; André Potvin; Jean-François Lalonde; Marc Hébert; Claude M H Demers
A 360-degree imagery-multisensor system for visualizing environmental parameters in architecture and urban spaces Article de journal
Dans: HardwareX, vol. 22, p. e00643, 2025, ISSN: 2468-0672.
@article{pmid40236517,
title = {A 360-degree imagery-multisensor system for visualizing environmental parameters in architecture and urban spaces},
author = {Mojtaba Parsaee and André Potvin and Jean-François Lalonde and Marc Hébert and Claude M H Demers},
doi = {10.1016/j.ohx.2025.e00643},
issn = {2468-0672},
year = {2025},
date = {2025-06-01},
journal = {HardwareX},
volume = {22},
pages = {e00643},
abstract = {This research has designed a 360-degree imagery-multisensor system aiming to capture and visualize environmental parameters in architecture and urban spaces. Unlike existing tools, this system enables simultaneous recording of both imagery and non-imagery environmental data, including lighting, thermal, air quality, sound, and physical space parameters, within a 360-degree field of view. Lighting conditions are captured using panoramic high dynamic range imagery, complemented by a 360-degree array of sensors measuring illuminance levels and spectral power distribution. Thermal and air quality conditions are recorded using 360-degree thermal imagery, combined with hygrometers and air particle meters. Sound levels are also monitored across the full 360-degree field. The system is built using 3D printing technologies and Raspberry Pi computers, equipped with various sensor modules. Custom Python scripts enable real-time data capture, processing, and visualization. This cost-effective, easy-to-manufacture, programmable, and customizable innovation is aimed at students and educators in design and architecture, as well as building engineers. Furthermore, integrating imagery and sensor data supports the development of immersive virtual and augmented reality applications, offering new opportunities for education and the exploration of effective design solutions.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Victoria Soto Linan; Véronique Rioux; Modesto Peralta; Nicolas Dupré; Marc Hébert; Martin Lévesque
Early detection of Parkinson’s disease: Retinal functional impairments as potential biomarkers Article de journal
Dans: Neurobiol Dis, vol. 208, p. 106872, 2025, ISSN: 1095-953X.
@article{pmid40090470,
title = {Early detection of Parkinson's disease: Retinal functional impairments as potential biomarkers},
author = {Victoria Soto Linan and Véronique Rioux and Modesto Peralta and Nicolas Dupré and Marc Hébert and Martin Lévesque},
doi = {10.1016/j.nbd.2025.106872},
issn = {1095-953X},
year = {2025},
date = {2025-05-01},
journal = {Neurobiol Dis},
volume = {208},
pages = {106872},
abstract = {BACKGROUND: Parkinson's disease is typically diagnosed after substantial neurodegeneration despite early non-motor symptoms manifesting decades earlier. These changes offer a promising avenue for diagnostic exploration, especially within the eye, which has been proposed as a "window to the brain."nnOBJECTIVE: The aim was to identify biomarkers by validating the use of electroretinography, a non-invasive technique, to detect early retinal function anomalies reflecting central dysfunction.nnMETHODS: Homozygous M83 transgenic mice (n = 10 males, 11 females), overexpressing human A53T α-synuclein, underwent behavioral tests and electroretinography measurements. Histological evaluation was performed at four months to analyze synucleinopathies and neurodegeneration. Electroretinography was also conducted with idiopathic PD patients (mean age 63.35 ± 7.73; disease duration 4.15 ± 2.06; H&Y score 2.07 ± 0.59; n = 12 males, 8 females) and healthy age-matched controls (mean age 61.65 ± 8.39; n = 9 males, 11 females).nnRESULTS: Rodent electroretinography revealed reduced photopic b-wave, PhNR b-wave, and PhNR-wave amplitudes at two and four months, particularly in females, indicating bipolar and retinal ganglion cell impairment. Based on retinal histological assessment, these changes might arise from α-synuclein pathology occurring in outer retinal layers. Likewise, the scotopic b-wave and PhNR waveform were similarly impaired in female participants with Parkinson's disease. The scotopic oscillatory potentials isolated further identified an attenuated amacrine cell output in females.nnCONCLUSIONS: Findings from both mice and human cohorts indicate that retinal functional impairments can be detected early in the progression of Parkinson's disease, particularly among females. These tools show promise in facilitating early diagnosis, disease monitoring, therapeutic intervention, and ultimately enhancing patient outcomes.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Marc-André Dubois; Charles-Antoine Pelletier; Valérie Jomphe; Richard E Bélanger; Simon Grondin; Marc Hébert
Validating skin electrodes: Paving the way for non-invasive ERG use in psychiatry Article de journal
Dans: Prog Neuropsychopharmacol Biol Psychiatry, vol. 137, p. 111305, 2025, ISSN: 1878-4216.
@article{pmid40023309,
title = {Validating skin electrodes: Paving the way for non-invasive ERG use in psychiatry},
author = {Marc-André Dubois and Charles-Antoine Pelletier and Valérie Jomphe and Richard E Bélanger and Simon Grondin and Marc Hébert},
doi = {10.1016/j.pnpbp.2025.111305},
issn = {1878-4216},
year = {2025},
date = {2025-03-01},
journal = {Prog Neuropsychopharmacol Biol Psychiatry},
volume = {137},
pages = {111305},
abstract = {BACKGROUND: Electroretinography (ERG) shows promise for identifying psychiatric biomarkers. The gold-standard approach relies on Dawson-Trick-Litzkow (DTL) electrodes and desktop equipment, but high costs and the expertise required for reliable electrode placement limit its implementation. This study evaluates a cost-effective alternative: a handheld ERG device paired with less invasive self-adhesive skin electrodes, which require minimal training.nnMETHODS: ERG responses to cone and rod luminance stimuli were recorded from 49 participants: 15 controls (8 women, 7 men), 18 with bipolar disorder (12 women, 6 men), and 16 with schizophrenia (4 women, 12 men). Each participant underwent ERG testing with both electrode types.nnRESULTS: Skin electrodes produced significantly smaller amplitudes and shorter latencies than DTL electrodes, except for longer scotopic b-wave latency. Women showed higher amplitudes and shorter latencies than men for both electrode types, with the photopic a-wave amplitude relative difference doubling when using skin electrodes. Reproducibility between eyes was high for both electrode types, though slightly lower for photopic a-wave with skin electrodes (ICC 0.76 vs. 0.86 for DTL).nnCONCLUSION: Skin electrodes paired with handheld ERG devices offer a viable, accessible alternative to traditional DTL electrodes paired with desktop equipment. This approach has the potential to expand the applicability of ERG in clinical settings by addressing barriers like cost, complexity, and invasiveness, while highlighting the need to consider sex differences in ERG assessments, particularly with skin electrodes.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Héloïse Rach; Ulker Kilic-Huck; Pierre A Geoffroy; Tristan Bourcier; Sophie Braun; Henri Comtet; Elisabeth Ruppert; Laurence Hugueny; Marc Hebert; Eve Reynaud; Patrice Bourgin
The electroretinography to identify biomarkers of idiopathic hypersomnia and narcolepsy type 1 Article de journal
Dans: J Sleep Res, vol. 34, no 1, p. e14278, 2025, ISSN: 1365-2869.
@article{pmid38993053,
title = {The electroretinography to identify biomarkers of idiopathic hypersomnia and narcolepsy type 1},
author = {Héloïse Rach and Ulker Kilic-Huck and Pierre A Geoffroy and Tristan Bourcier and Sophie Braun and Henri Comtet and Elisabeth Ruppert and Laurence Hugueny and Marc Hebert and Eve Reynaud and Patrice Bourgin},
doi = {10.1111/jsr.14278},
issn = {1365-2869},
year = {2025},
date = {2025-02-01},
journal = {J Sleep Res},
volume = {34},
number = {1},
pages = {e14278},
abstract = {Hypersomnia spectrum disorders are underdiagnosed and poorly treated due to their heterogeneity and absence of biomarkers. The electroretinography has been proposed as a proxy of central dysfunction and has proved to be valuable to differentiate certain psychiatric disorders. Hypersomnolence is a shared core feature in central hypersomnia and psychiatric disorders. We therefore aimed to identify biomarkers by studying the electroretinography profile in patients with narcolepsy type 1, idiopathic hypersomnia and in controls. Cone, rod and retinal ganglion cells electrical activity were recorded with flash-electroretinography in non-dilated eye of 31 patients with idiopathic hypersomnia (women 84%, 26.6 ± 5.9 years), 19 patients with narcolepsy type 1 (women 63%, 36.6 ± 12.7 years) and 43 controls (women 58%, 30.6 ± 9.3 years). Reduced cone a-wave amplitude (p = 0.039) and prolonged cone (p = 0.022) and rod b-wave (p = 0.009) latencies were observed in patients with narcolepsy type 1 as compared with controls, while prolonged photopic negative response-wave latency (retinal ganglion cells activity) was observed in patients with idiopathic hypersomnia as compared with controls (p = 0.033). The rod and cone b-wave latency clearly distinguished narcolepsy type 1 from idiopathic hypersomnia and controls (area under the curve > 0.70), and the photopic negative response-wave latency distinguished idiopathic hypersomnia and narcolepsy type 1 from controls with an area under the curve > 0.68. This first original study shows electroretinography anomalies observed in patients with hypersomnia. Narcolepsy type 1 is associated with impaired cone and rod responses, whereas idiopathic hypersomnia is associated with impaired retinal ganglion cells response, suggesting different phototransduction alterations in both hypersomnias. Although these results need to be confirmed with a larger sample size, the electroretinography may be a promising tool for clinicians to differentiate hypersomnia subtypes.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}
Julia Maruani; Lily Vissouze; Marc Hebert; Heloise Rach; Feriel Zehani; Michel Lejoyeux; Patrice Bourgin; Pierre A Geoffroy
Pupillary response to blue light as a biomarker of seasonal pattern in Major Depressive Episode: A clinical study using pupillometry Article de journal
Dans: Psychiatry Res, vol. 344, p. 116333, 2025, ISSN: 1872-7123.
@article{pmid39721100,
title = {Pupillary response to blue light as a biomarker of seasonal pattern in Major Depressive Episode: A clinical study using pupillometry},
author = {Julia Maruani and Lily Vissouze and Marc Hebert and Heloise Rach and Feriel Zehani and Michel Lejoyeux and Patrice Bourgin and Pierre A Geoffroy},
doi = {10.1016/j.psychres.2024.116333},
issn = {1872-7123},
year = {2025},
date = {2025-02-01},
journal = {Psychiatry Res},
volume = {344},
pages = {116333},
abstract = {Depressive disorders are characterized by disturbances in light signal processing. More specifically, an alteration of the melanopsin response is suggested. The post-illumination pupillary response (PIPR) to blue light (post-blue PIPR) is increasingly used as a marker of the activity of intrinsically photosensitive melanopsin ganglion cells (ipRGCs). We hypothesized that individuals with Major Depressive Episode (MDE) who exhibited a higher vulnerability to season patterns showed a decreased ability to transmit light signals to the brain. We explored the correlation between the post-blue PIPR and the Global Seasonality Score (GSS) in 21 patients with MDE. The GSS was assessed using the Seasonal Pattern Assessment Questionnaire (SPAQ). The results revealed that decreased relative and absolute post-blue PIPR, suggesting a melanopsinergic hyposensitivity, were associated independently and significantly with higher seasonality in the psychological factor including a greater seasonal variation in sleep duration, mood, energy level and social activity, but were not associated with higher seasonality in the dietary factor (including weight and appetite seasonal variations) or with the severity of anxiety, depression, or sleep disturbances. Interestingly, mediation analyses highlight independent bidirectional effects of high vulnerability to season of psychological factors and decreased ipRGC sensitivity. Post-blue PIPR could be an objective marker of seasonal changes in daylight exposure in patients with MDE. Further research could explore post-blue PIPR as a state or trait biomarker for depressive disorders and the seasonal pattern, and its potential role in predicting therapeutic response to light therapy.},
keywords = {},
pubstate = {published},
tppubtype = {article}
}









